Bone Biologics Corp

BBLG

Bone Biologics Corp

BBLG

Insider Sentiment (TTM):

Last Purchase:2023-09-13Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,412Shares Outstanding:1,795,260Institutional Ownership Pct.:0.25%

Earnings Market Reaction:

Filing Date:2026-05-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

ISRG EW STE ZBH ALGN MSA

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Assets Current	5	6	6	7	3	4	4	3	4	4	-	-
Cash	5	5	6	7	3	3	4	2	3	3	4	7
Interest Receivable	0	0	-	-	-	-	-	-	-	-	-	-
Prepaid Expense Current	0	0	0	0	0	0	0	0	0	0	1	1
Assets	5	6	6	7	3	4	4	3	4	4	5	8
Liabilities And Stockhold…
Liabilities	0	0	0	0	0	0	0	0	0	1	1	2
Accounts Payable And Accrued Liabilities Current	0	0	0	0	0	0	0	0	0	0	1	2
Liabilities Current
Liabilities Current	0	0	0	0	0	0	0	0	0	1	1	2
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	5	5	6	7	3	3	4	3	4	3	4	6
Additional Paid In Capital	94	94	93	93	89	89	87	85	85	84	83	83
Retained Earnings Accumulated Deficit	-89	-88	-87	-87	-86	-85	-83	-83	-82	-81	-79	-77
Liabilities And Stockholders Equity	5	6	6	7	3	4	4	3	4	4	5	8
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	-	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	4	4	4	-	3	4	4	3	2	2	31	31
Shares Outstanding	4	4	4	3	3	4	4	3	2	2	31	31

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.65%	11.81%	-	-	-	-	-	-	-	-	-	-
2025	9.73%	-20.32%	-37.67%	-1.70%	6.38%	-9.36%	20.62%	-3.75%	2.50%	-6.72%	14.29%	2.52%
2024	-33.04%	-48.70%	18.26%	-17.16%	39.05%	2.37%	-4.65%	-13.95%	-13.95%	-6.48%	-27.74%	-23.27%
2023	0.18%	-73.69%	-75.14%	-45.04%	-52.80%	-58.08%	-15.80%	28.50%	-20.25%	-26.03%	-46.73%	-39.05%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	16.09	13.85	19.00	17.24	12.59	10.22	14.87	11.22	23.32	4.50	-	-
Quick Ratio	16.06	13.82	18.97	17.22	12.55	10.20	14.80	11.16	23.26	4.48	-	-
Working Capital	4.67M	5.38M	6.02M	6.60M	2.91M	3.48M	3.79M	2.91M	3.67M	2.91M	-	-
Leverage & Debt
Debt to Equity	0.07	0.08	0.06	0.06	0.09	0.11	0.07	0.10	0.04	0.29	0.31	0.34
Interest Coverage TTM	-	-	-	-	-	-16,545.73	-6,342.01	-4,349.52	-4,584.75	-5,047.27	-6,286.44	-8,835.14
Debt Ratio	0.06	0.07	0.05	0.06	0.08	0.10	0.07	0.09	0.04	0.22	-	-
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-
Per Share Metrics
Diluted EPS TTM	-1.59	-2.65	-2.20	-2.52	-2.68	-2.71	-2.36	-4.38	-4.62	-5.67	-2.77	-2.85
Free Cash Flow Per Share TTM	-1.43	-2.29	-1.85	-1.98	-2.35	-2.72	-2.73	-5.79	-7.19	-6.05	-4.04	-3.60
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-32.97%	-24.40%	-4.70%	-17.56%	-30.16%	-54.04%	-36.35%	-11.81%	35.51%	502.76%	154.53%	214.49%
EPS Growth (1Y)	-40.56%	-2.34%	-6.88%	-42.41%	-42.01%	-52.20%	-14.68%	53.59%	106.71%	445.85%	60.08%	128.42%
Valuation Metrics
P/E TTM	-0.69	-0.55	-1.27	-1.60	-1.79	-2.08	-5.41	-1.67	-2.77	-4.78	-12.32	-24.07
P/B TTM	0.42	0.32	0.83	1.02	2.62	2.46	5.91	2.94	4.60	14.73	21.12	24.55
Market Cap	1.97M	1.70M	5.01M	6.74M	7.64M	8.56M	22.42M	8.56M	16.89M	42.82M	80.13M	139.74M
Enterprise Value	-2.56M	-3.63M	-1.04M	103.18K	4.89M	5.24M	18.85M	6.22M	13.67M	39.79M	75.67M	132.73M
Calculated Values
Free Cash Flow TTM	-2.57M	-2.69M	-3.33M	-3.31M	-3.75M	-4.12M	-4.79M	-6.77M	-9.51M	-9.56M	-9.49M	-7.33M
Net Debt	-4.53M	-5.33M	-6.05M	-6.64M	-2.75M	-3.33M	-3.57M	-2.33M	-3.23M	-3.03M	-4.45M	-7.01M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-09-13Purchase

Owner: Walsh, Deina H

Title: Chief Financial Officer

Shares: 8,000

Price/Share: $0.64

Value: $5,120.00

Shares Owned: 15,000

Relationship: Officer

Ownership: Direct

2023-09-11Purchase

Owner: Frelick, Jeff

Title: Chief Executive Officer

Shares: 9,500

Price/Share: $0.69

Value: $6,555.00

Shares Owned: 17,204

Relationship: Officer

Ownership: Direct

2023-09-06Purchase

Owner: Walsh, Deina H

Title: Chief Financial Officer

Shares: 7,000

Price/Share: $0.70

Value: $4,900.00

Shares Owned: 7,000

Relationship: Officer

Ownership: Direct

2023-08-31Purchase

Owner: Frelick, Jeff

Title: Chief Executive Officer

Shares: 7,600

Price/Share: $0.66

Value: $5,016.00

Shares Owned: 7,704

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-09-13	Walsh, Deina H	Officer	Chief Financial Officer	Direct	Purchase	8,000	0.64	$5,120.00	15,000	4
2023-09-11	Frelick, Jeff	Officer	Chief Executive Officer	Direct	Purchase	9,500	0.69	$6,555.00	17,204	4
2023-09-06	Walsh, Deina H	Officer	Chief Financial Officer	Direct	Purchase	7,000	0.70	$4,900.00	7,000	4
2023-08-31	Frelick, Jeff	Officer	Chief Executive Officer	Direct	Purchase	7,600	0.66	$5,016.00	7,704	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

0.25%

Inst. Shares: 4,412

Shares Outstanding: 1,795,260

2025-12-31

4.35%

Inst. Shares: 51,074

Shares Outstanding: 1,174,869

2025-09-30

0.73%

Inst. Shares: 13,145

Shares Outstanding: 1,795,097

2025-06-30

0.03%

Inst. Shares: 455

Shares Outstanding: 1,673,361

2025-03-31

1.64%

Inst. Shares: 26,050

Shares Outstanding: 1,591,854

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,412	1,795,260	0.25%
2025-12-31	51,074	1,174,869	4.35%
2025-09-30	13,145	1,795,097	0.73%
2025-06-30	455	1,673,361	0.03%
2025-03-31	26,050	1,591,854	1.64%
2024-12-31	45,591	1,517,760	3.00%
2024-09-30	63,603	1,753,926	3.63%
2024-06-30	39,925	1,168,944	3.42%
2024-03-31	41,854	1,321,856	3.17%
2023-12-31	1,229	1,578,822	0.08%
2023-09-30	304,418	2,351,124	12.95%
2023-06-30	338,927	2,035,848	16.65%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Bone Biologics Corp (BBLG) — SEC Financial Statements & Analysis

Bone Biologics Corp (BBLG) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. Bone Biologics Corp trades on Nasdaq as: BBLG, BBLGW. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Bone Biologics Corp reported a Debt-to-Equity ratio of 0.07x, a Price-to-Book (P/B) ratio of 0.42 (TTM), at a market cap of $1.97M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.07x
P/B TTM: 0.42
Market Cap: $1.97M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Bone Biologics Corp in?

Bone Biologics Corp (BBLG) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is BBLG's market cap?

Bone Biologics Corp (BBLG) has a market capitalization of $1.97M as of 2026-03-31.

What exchange does BBLG trade on?

Bone Biologics Corp (BBLG) trades on the Nasdaq.

Where is Bone Biologics Corp incorporated?

Bone Biologics Corp is incorporated in DE.

Bone Biologics Corp (BBLG) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.